Dr. Vivian B. Diaz Melendez, M.D Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: #3 Calle Font Martelo, Humacao, PR 00791 Phone: 787-960-3314 |
Dr. Graciany Miranda, MD. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Dufresne Street No.7, Humacao, PR 00791 Phone: 787-852-5260 Fax: 787-285-7958 |
Dr. Ivan Aponte Aponte, M.D Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 263 Calle Font Martelo, Humacao, PR 00791 Phone: 787-850-6009 Fax: 787-850-6204 |
Dr. Ivelisse Irizarry, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 355 Calle Font Martelo, Humacao, PR 00791 Phone: 787-852-0768 |
Dr. Deana Hallman, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: Font Martelo Ave., Ryder Memorial Hospital, Inc./oncology Unit, Humacao, PR 00792 Phone: 787-852-0768 |
Joel Lopez-figueroa, Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 12 Calle Victoria, Legacy Medical Center Suite 22, Humacao, PR 00791 Phone: 787-266-9151 Fax: 787-266-9152 |
Dr. Alma V. Rivera, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 1 Calle Font Martelo E, Ryder Memorial Hospital. Inc., Humacao, PR 00791 Phone: 787-852-0768 |
News Archive
VIB scientists connected to the K.U.Leuven have identified a molecule that can form the basis for a new therapy for Alzheimer's disease.
An enormous high tech machine is providing new hope to patients across the country with inoperable tumors. Proton therapy is a precise radiation technique that reduces the side effects often accompanied by traditional treatment options. Thanks to this remarkable technology, a new proton therapy center at UF Health Cancer Center - Orlando Health is saving the eyesight of a new mother who was diagnosed with a tumor behind her eye during her second trimester of pregnancy.
Recent large-scale genomic analyses have uncovered dozens of common genetic variants that are associated with breast cancer. Each variant, however, contributes only a tiny amount to a person's overall risk of developing the disease.
Skills for Health, Health Education England, and Skills for Care have announced a new Framework to support person-centered approaches for the health and social care workforce.
Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.
› Verified 8 days ago